QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: mol.106.022954v1 70/1/415    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, S. J. Articles by Kim, S. G. Search for Related Content PubMed PubMed Citation Articles by Lee, S. J. Articles by Kim, S. G.

Peroxisome Proliferator-Activated Receptor- and Retinoic Acid X Receptor Represses the TGF1 Gene via PTEN-Mediated p70 Ribosomal S6 Kinase-1 Inhibition: Role for Zf9 Dephosphorylation

National Research Laboratory, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea

Peroxisome proliferator-activated receptor (PPAR)- and retinoic acid X receptor (RXR) heterodimer regulates cell growth and differentiation. Zinc finger transcription factor-9 (Zf9), whose phosphorylation promotes target genes, is a transcription factor essential for transactivation of the transforming growth factor (TGF)-1 gene. This study investigated whether activation of PPAR-RXR heterodimer inhibits TGF1 gene transcription and Zf9 phosphorylation and, if so, what signaling pathway regulates it. Either 15-deoxy-(12,14)-prostaglandin J₂ (PGJ₂) or 9-cis-retinoic acid (RA) treatment decreased the TGF1 mRNA level in L929 fibroblasts. PGJ₂ + RA, compared with individual treatment alone, synergistically inhibited the TGF1 gene expression, which was abrogated by PPAR antagonists. Likewise, PGJ₂ + RA decreased luciferase expression from the TGF1 gene promoter. Promoter deletion analysis of the TGF1 gene revealed that pGL3-323 making up to -323-base pair region, but lacking PPAR-responsive elements, responded to PGJ₂ + RA. PGJ₂ + RA treatment inhibited the activity of p70 ribosomal S6 kinase-1 (S6K1), abolishing Zf9 phosphorylation at serine as did rapamycin [a mammalian target of rapamycin (mTOR) inhibitor]. Zf9 dephosphorylation by PGJ₂ + RA was reversed by transfection of cells with the plasmid encoding constitutively active S6K1 (CA-S6K1). Transfection with dominant negative S6K1 inhibited the TGF1 gene. TGF1 gene repression by PGJ₂ + RA was consistently antagonized by CA-S6K1. Ectopic expression of PPAR1 and RXR repressed pGL3-323 transactivation with S6K1 inhibition, which was abrogated by CA-S6K1 transfection. PGJ₂ + RA induced phosphatase and tensin homolog deleted on chromosome 10 (PTEN), whose overexpression repressed the TGF1 gene through S6K1 inhibition, decreasing extracellular signal-regulated kinase 1/2-90-kDa ribosomal S6 kinase 1 and Akt-mTOR phosphorylations. Data indicate that activation of PPAR-RXR heterodimer represses the TGF1 gene and induces Zf9 dephosphorylation via PTEN-mediated S6K1 inhibition, providing insight into pharmacological manipulation of the TGF1 gene regulation.

Address correspondence to: Dr. Sang Geon Kim, College of Pharmacy, Seoul National University, Sillim-dong, Kwanak-gu, Seoul 151-742, Korea. E-mail: sgk{at}snu.ac.kr

This article has been cited by other articles:

				K. S. Lee, S. J. Park, S. R. Kim, K. H. Min, K. Y. Lee, Y. H. Choe, S. H. Hong, Y. R. Lee, J. S. Kim, S. J. Hong, et al. Inhibition of VEGF blocks TGF-{beta}1 production through a PI3K/Akt signalling pathway Eur. Respir. J., March 1, 2008; 31(3): 523 - 531. [Abstract] [Full Text] [PDF]

				R. Kratzner, F. Frohlich, K. Lepler, M. Schroder, K. Roher, C. Dickel, M. V. Tzvetkov, T. Quentin, E. Oetjen, and W. Knepel A Peroxisome Proliferator-Activated Receptor {gamma}-Retinoid X Receptor Heterodimer Physically Interacts with the Transcriptional Activator PAX6 to Inhibit Glucagon Gene Transcription Mol. Pharmacol., February 1, 2008; 73(2): 509 - 517. [Abstract] [Full Text] [PDF]